Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -76.60x is 164% below its 3-year average of -29.02x, near the low end of its 3-year range (-76.60x–-13.32x).
As of the fiscal period ended Saturday, June 30, 2018. 75.41% below its 12-month average of -43.67x.
Reported quarterly interest coverage; no daily interpolation. Q2 FY2018 (2018-06-30): -76.60x.
INTEREST COVERAGE RATIO
-76.60x
INTEREST COVERAGE RATIO AVG TTM
-43.67x
INTEREST COVERAGE RATIO AVG 3Y
-29.02x
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-75.41%
CURRENT VS 3Y AVG
-163.97%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-5.68x
median of 460 covered companies
CURRENT VS SECTOR MEDIAN
-1248.59%
vs the sector median at left
Pulmatrix, Inc.
Market Cap
$5.24M
Interest Coverage Ratio
-76.60x
TTM Avg
-43.67x
3Y Avg
-29.02x
5Y Avg
N/A
Market Cap
$5.24M
Interest Coverage Ratio
-2.90x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.24M
Interest Coverage Ratio
-1174.37x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.21M
Interest Coverage Ratio
1324.50x
TTM Avg
1324.50x
3Y Avg
1324.50x
5Y Avg
1324.50x
Market Cap
$5.21M
Interest Coverage Ratio
-25.56x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.17M
Interest Coverage Ratio
-13.75x
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.20M
Interest Coverage Ratio
-10.70x
TTM Avg
10.43x
3Y Avg
9.52x
5Y Avg
9.52x
Market Cap
$5.60M
Interest Coverage Ratio
N/A
TTM Avg
2443.20x
3Y Avg
2443.20x
5Y Avg
2443.20x
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Pulmatrix, Inc. (PULM) | $5.24M | -76.60x | -43.67x | -29.02x | N/A |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.24M | -2.90x | N/A | N/A | N/A |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.24M | -1174.37x | N/A | N/A | N/A |
| Alzamend Neuro Inc (ALZN)vs › | $5.21M | 1324.50x | 1324.50x | 1324.50x | 1324.50x |
| Lunai Bioworks Inc. (LNAI)vs › | $5.21M | -25.56x | N/A | N/A | N/A |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.17M | -13.75x | N/A | N/A | N/A |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.20M | -10.70x | 10.43x | 9.52x | 9.52x |
| Imunon, Inc. (IMNN)vs › | $4.98M | N/A | 1.00x | 1.02x | 1.02x |
| enVVeno Medical Corporation (NVNO)vs › | $5.60M | N/A | 2443.20x | 2443.20x | 2443.20x |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.84M | N/A | 1.10x | 1.10x | 1.10x |
Interest Coverage
-76.6x
Debt/Equity
0.00
Current Ratio
4.70
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2018-06-30 | -76.60x |
| 2018-03-31 | -48.25x |
| 2017-12-31 | -33.81x |
| 2017-09-30 | -28.13x |
| 2017-06-30 | -31.56x |
| 2017-03-31 | -17.71x |
| 2016-12-31 | -35.86x |
| 2016-09-30 | -13.32x |
| 2016-06-30 | -40.04x |
| 2016-03-31 | -24.41x |
| 2015-12-31 | -19.34x |
| 2015-09-30 | -21.19x |
| 2015-06-30 | -34.61x |
